Global Cancer Vaccine Market Research Report 2022 - Market Size, Current Insights and Development Trends

Global Cancer Vaccine Market Research Report 2022 - Market Size, Current Insights and Development Trends

A cancer vaccine is a type of immunotherapy that boost the body's natural defenses by stimulating the immune system to recognize and cure cancerous cells.

The report focuses on the Cancer Vaccine market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Cancer Vaccine market.

Major Players in the Cancer Vaccine market are:

Bavarian Nordic
Sanpower Group
Sanofi Pasteur
Gritstone Oncology
Dynavax Technologies Corporation
Astellas Pharma Inc.
Immunomic Therapeutics, Inc.
Merck & Co., Inc.
Astrazeneca Plc.
PaxVax Corporation.
Aduro BioTech Inc.
CSL Limited
Glaxosmithkline Plc
Pfizer

On the basis of types, the Cancer Vaccine market is primarily split into:

Preventive Cancer Vaccines
Therapeutic Cancer Vaccines

On the basis of applications, the market covers:

Cervical Cancer
Prostate Cancer
Others

Major Regions or countries covered in this report:

United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others

Years considered for this report:

Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029


1 Cancer Vaccine Market Overview
1.1 Product Overview and Scope of Cancer Vaccine Market
1.2 Cancer Vaccine Market Segment by Type
1.2.1 Global Cancer Vaccine Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Cancer Vaccine Market Segment by Application
1.3.1 Cancer Vaccine Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Cancer Vaccine Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Cancer Vaccine (2017-2029)
1.5.1 Global Cancer Vaccine Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Cancer Vaccine Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Cancer Vaccine Industry
1.7 Impact of Carbon Neutrality on the Cancer Vaccine Industry
2 Cancer Vaccine Market Upstream and Downstream Analysis
2.1 Cancer Vaccine Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Cancer Vaccine Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Bavarian Nordic
3.1.1 Bavarian Nordic Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Cancer Vaccine Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Sanpower Group
3.2.1 Sanpower Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Cancer Vaccine Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Sanofi Pasteur
3.3.1 Sanofi Pasteur Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Cancer Vaccine Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Gritstone Oncology
3.4.1 Gritstone Oncology Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Cancer Vaccine Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Dynavax Technologies Corporation
3.5.1 Dynavax Technologies Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Cancer Vaccine Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Astellas Pharma Inc.
3.6.1 Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Cancer Vaccine Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Immunomic Therapeutics, Inc.
3.7.1 Immunomic Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Cancer Vaccine Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Merck & Co., Inc.
3.8.1 Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Cancer Vaccine Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Astrazeneca Plc.
3.9.1 Astrazeneca Plc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Cancer Vaccine Market Performance (2017-2022)
3.9.4 Business Overview
3.10 PaxVax Corporation.
3.10.1 PaxVax Corporation. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Cancer Vaccine Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Aduro BioTech Inc.
3.11.1 Aduro BioTech Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Cancer Vaccine Market Performance (2017-2022)
3.11.4 Business Overview
3.12 CSL Limited
3.12.1 CSL Limited Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Cancer Vaccine Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Glaxosmithkline Plc
3.13.1 Glaxosmithkline Plc Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Cancer Vaccine Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Pfizer
3.14.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Cancer Vaccine Market Performance (2017-2022)
3.14.4 Business Overview
4 Global Cancer Vaccine Market Landscape by Player
4.1 Global Cancer Vaccine Sales and Share by Player (2017-2022)
4.2 Global Cancer Vaccine Revenue and Market Share by Player (2017-2022)
4.3 Global Cancer Vaccine Average Price by Player (2017-2022)
4.4 Global Cancer Vaccine Gross Margin by Player (2017-2022)
4.5 Cancer Vaccine Market Competitive Situation and Trends
4.5.1 Cancer Vaccine Market Concentration Rate
4.5.2 Cancer Vaccine Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Cancer Vaccine Sales, Revenue, Price Trend by Type
5.1 Global Cancer Vaccine Sales and Market Share by Type (2017-2022)
5.2 Global Cancer Vaccine Revenue and Market Share by Type (2017-2022)
5.3 Global Cancer Vaccine Price by Type (2017-2022)
5.4 Global Cancer Vaccine Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Cancer Vaccine Sales, Revenue and Growth Rate of Preventive Cancer Vaccines (2017-2022)
5.4.2 Global Cancer Vaccine Sales, Revenue and Growth Rate of Therapeutic Cancer Vaccines (2017-2022)
6 Global Cancer Vaccine Market Analysis by Application
6.1 Global Cancer Vaccine Consumption and Market Share by Application (2017-2022)
6.2 Global Cancer Vaccine Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Cancer Vaccine Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Cancer Vaccine Consumption and Growth Rate of Cervical Cancer (2017-2022)
6.3.2 Global Cancer Vaccine Consumption and Growth Rate of Prostate Cancer (2017-2022)
6.3.3 Global Cancer Vaccine Consumption and Growth Rate of Others (2017-2022)
7 Global Cancer Vaccine Sales and Revenue Region Wise (2017-2022)
7.1 Global Cancer Vaccine Sales and Market Share, Region Wise (2017-2022)
7.2 Global Cancer Vaccine Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Cancer Vaccine Market Forecast (2022-2029)
8.1 Global Cancer Vaccine Sales, Revenue Forecast (2022-2029)
8.1.1 Global Cancer Vaccine Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Cancer Vaccine Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Cancer Vaccine Price and Trend Forecast (2022-2029)
8.2 Global Cancer Vaccine Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.2.3 China Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.2.5 India Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.3 Global Cancer Vaccine Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Cancer Vaccine Revenue and Growth Rate of Preventive Cancer Vaccines (2022-2029)
8.3.2 Global Cancer Vaccine Revenue and Growth Rate of Therapeutic Cancer Vaccines (2022-2029)
8.4 Global Cancer Vaccine Consumption Forecast by Application (2022-2029)
8.4.1 Global Cancer Vaccine Consumption Value and Growth Rate of Cervical Cancer (2022-2029)
8.4.2 Global Cancer Vaccine Consumption Value and Growth Rate of Prostate Cancer (2022-2029)
8.4.3 Global Cancer Vaccine Consumption Value and Growth Rate of Others (2022-2029)
8.5 Cancer Vaccine Market Forecast Under COVID-19
9 Industry Outlook
9.1 Cancer Vaccine Market Drivers Analysis
9.2 Cancer Vaccine Market Restraints and Challenges
9.3 Cancer Vaccine Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Cancer Vaccine Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Cancer Vaccine Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Cancer Vaccine Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings